Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Du Preez, Stanley, Eaton-Fitch, Natalie, Smith, Peter K et al. · Biomolecules · 2023 · DOI
Quick Summary
This study looked at how calcium moves into immune cells called NK cells in ME/CFS patients compared to healthy people. Researchers found that calcium enters these cells differently in ME/CFS patients—it flows in more slowly when activated but responds more strongly when blocked. This suggests a problem with a specific calcium channel called TRPM7 that may be involved in why NK cells don't work properly in ME/CFS.
Why It Matters
NK cell dysfunction is a well-documented feature of ME/CFS, and this study identifies a specific molecular mechanism—impaired calcium handling through TRPM7—that could explain their reduced antiviral and anti-tumor killing capacity. Understanding this ion channel defect opens potential therapeutic targets and may eventually lead to biomarkers for diagnosis or treatment monitoring.
Observed Findings
Slope of Ca2+ influx was significantly reduced in ME/CFS NK cells following TRPM7 activation (p < 0.05)
Half-time to maximal response during TRPM7 desensitization was significantly reduced in healthy control cells (p < 0.05)
Amplitude of Ca2+ response during desensitization was significantly reduced in healthy controls compared to ME/CFS patients (p < 0.001)
TRPM7-dependent Ca2+ handling shows opposing patterns of dysregulation: reduced activation response but enhanced antagonism response in ME/CFS
Inferred Conclusions
TRPM7-dependent calcium influx is functionally altered in ME/CFS NK cells, suggesting impaired calcium signaling during immune activation
The altered response pattern (reduced agonism, exaggerated antagonism response) suggests abnormal channel regulation or desensitization kinetics in ME/CFS
These findings support the hypothesis that ME/CFS represents a TRP ion channelopathy affecting immune cell function
Remaining Questions
Does TRPM7 dysfunction directly explain the reduced cytotoxic function of NK cells in ME/CFS, or are other mechanisms also involved?
Is the TRPM7 alteration present in other immune cell types beyond NK cells, and does it affect other TRP channels as suggested by prior TRPM3 findings?
What This Study Does Not Prove
This study does not prove that TRPM7 dysfunction causes ME/CFS, only that it is altered in the condition. The ex vivo findings in isolated cells may not fully reflect what happens in the body. It does not establish whether this is a primary defect or a secondary consequence of other disease processes, nor does it demonstrate that correcting TRPM7 function would improve patient symptoms.